Enterra® Therapy for chronic nausea and vomiting due to gastroparesis | Enterra Medical, Inc.
Enterra® Therapy is a surgical option for people unable to control chronic symptoms of gastroparesis. Enterra Medical is a dedicated team with a singular focus: to help more people suffering from chronic gastroparesis live better lives through advancing technology and accelerating access to the Enterra Therapy.
Overview
Enterra Medical, Inc. is a medical device company based in Minneapolis, Minnesota, focused on treating chronic gastroparesis. The company develops Enterra® Therapy, a surgical option for individuals who struggle to manage chronic nausea and vomiting due to this condition. Enterra Therapy, which received FDA approval under a Humanitarian Device Exemption in 2000, is the first and only implantable therapy that utilizes gastric electrical stimulation (GES) to alleviate symptoms associated with diabetic or idiopathic gastroparesis. More than 15,000 patients have undergone this treatment to help them return to their daily activities. Enterra Medical aims to expand access to this therapy for patients aged 18 to 70 years suffering from chronic intractable nausea and vomiting related to gastroparesis.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Minneapolis, Minnesota
- Type
- Privately Held
- Founded
- 2022
- Followers
- 5,641
- Specialties
- nausea, vomiting, gastroparesis, diabetes, gastric electrical stimulation, neurostimulation, neurostimulator, GES, intractable nausea, and gastroenterology
- Locations
- Minneapolis, Minnesota, US